Search results for "Anticoagulation"
Switching to newer oral anticoagulant didn't benefit frail older patients with afib
A randomized trial that switched some frail atrial fibrillation patients from vitamin K antagonists (VKAs) to non-vitamin K oral anticoagulants found that such patients had more bleeding and no decrease in thromboembolic events compared to those who stayed on a VKA.
https://acphospitalist.acponline.org/archives/2023/09/06/switching-to-newer-oral-anticoagulant-didnt-benefit-frail-older-patients-with-afib.htm
6 Sep 2023
FDA provides info on stimulant shortage
Also, a sterilizer for 3D-printed medical devices, a drug for postpartum depression, and an RSV vaccine for pregnant patients were approved, among other recent FDA actions.
https://acphospitalist.acponline.org/archives/2023/08/30/fda-provides-info-on-stimulant-shortage.htm
30 Aug 2023
Chest physicians make 11 recommendations on antithrombotic therapy in COVID-19
The recommendations on prevention and management of arterial thrombosis and thromboembolism are not a major departure from prepandemic ones, according to an expert panel from the American College of Chest Physicians.
https://acphospitalist.acponline.org/archives/2023/07/05/free/chest-physicians-make-11-recommendations-on-antithrombotic-therapy-in-covid-19.htm
5 Jul 2023
Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19
Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
https://acphospitalist.acponline.org/archives/2023/03/29/free/higher-dose-prophylactic-anticoagulation-needed-to-prevent-thrombosis-in-hypoxemic-covid-19.htm
29 Mar 2023
AHA issues scientific statement on managing atrial fibrillation during hospitalization
Acute manifestations of atrial fibrillation warrant clinical attention during hospitalization, at transitions of care, and over the long term, said the American Heart Association (AHA) statement, which reviewed triggers and treatments for the condition.
https://acphospitalist.acponline.org/archives/2023/03/22/free/aha-issues-scientific-statement-on-managing-atrial-fibrillation-during-hospitalization.htm
22 Mar 2023
Superior vena cava occlusion without malignancy
A patient with end-stage renal disease presented with one week of facial and left-arm edema.
https://acphospitalist.acponline.org/archives/2023/03/15/free/superior-vena-cava-occlusion-without-malignancy.htm
15 Mar 2023
Aspirin noninferior to LMWH for prophylaxis after traumatic fractures, trial finds
All-cause mortality at 90 days was similar in hospitalized patients randomized to aspirin versus low-molecular-weight heparin (LMWH), and rates of deep venous thrombosis and pulmonary embolism were also low in both groups.
https://acphospitalist.acponline.org/archives/2023/01/25/aspirin-noninferior-to-lmwh-for-prophylaxis-after-traumatic-fractures-trial-finds.htm
25 Jan 2023
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared the direct oral anticoagulants (DOACs) apixaban, edoxaban, and rivaroxaban to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://acphospitalist.acponline.org/archives/2023/01/04/doacs-more-effective-cost-effective-than-lmwh-for-cancer-associated-thrombosis.htm
4 Jan 2023
The year's top headlines
We collected the top five most read ACP Hospitalist articles of 2022 and identified some themes.
https://acphospitalist.acponline.org/archives/2022/12/28/the-years-top-headlines.htm
28 Dec 2022
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://acphospitalist.acponline.org/archives/2022/12/14/aha-statement-reviews-efficacy-safety-of-cam-therapies-in-patients-with-heart-failure.htm
14 Dec 2022